Key Market Indicators
Belgium's insulin import market is projected to reach nearly $190 million by 2028, up from approximately $164 million in 2023, reflecting an annual growth rate of 2.2%. Since 2004, the demand for insulin in Belgium has grown steadily, with a yearly increase of 3%. On the export front, Belgian insulin exports are expected to climb to about $90 million by 2028, compared to $75 million in 2023, marking an average annual growth rate of 2.8%. Since 2004, the country's insulin supply has increased by 4.4% each year. In 2023, Belgium ranked eighth in global insulin exports, with Hungary narrowly ahead at around $75 million. Leading the rankings were France, Italy, and China, occupying the second, third, and fourth positions, respectively.
